Perm Medical JournalPerm Medical Journal0136-14492687-1408Eco-Vector5767410.17816/pmj37579-89Research ArticlePreparation of primary glial tumor cell linesShamovaT. V.<p>Junior Researcher</p>tanyshamova@mail.ruSitkovskayaA. O.<p>Researcher, Acting Head of Laboratory of Cell Technologies</p>tanyshamova@mail.ruRostorguevE. E.<p>Candidate of Medical Sciences, Head of Department of Neurooncology, neurosurgeon</p>tanyshamova@mail.ruKuznetsovaN. S.<p>oncologist, Department of Neurooncology</p>tanyshamova@mail.ruKavitskyS. E.<p>Candidate of Medical Sciences, neurosurgeon, Department of Neorooncology</p>tanyshamova@mail.ruNational Medical Research Center for Oncology0712202037579890701202107012021Copyright © 2021, Shamova T.V., Sitkovskaya A.O., Rostorguev E.E., Kuznetsova N.S., Kavitsky S.E.2021<p><strong>Objective.</strong> The aim of this work was to obtain the primary cell lines of brain malignant tumors using the explant method.</p>
<p><strong>Materials and methods. </strong>Thirteen patients of both sexes, aged 22 to 66, were recruited. The tumor material of the patients was fragmented and placed in flasks with complete nutrient medium for glial tumor cells. Subsequently, the material was photographed at various stages of cultivation, the cell morphology was determined, and the rate of monolayer formation at the zero and first passages was assessed.</p>
<p><strong>Results.</strong> As a result, thirteen primary human cell lines of glial tumors were obtained: six glioblastoma lines, two glioblastoma lines with anaplastic astrocytoma, one anaplastic oligodendroglioma line, one diffuse astrocytoma line, one oligoastrocytoma line and one diffuse protoplasmic astrocytoma line, one anaplastic astrocytoma line. In the culture of diffuse astrocytoma, there were observed the cells forming a network at the bottom of the flask. In the culture of anaplastic astrocytoma at a confluence of 3050 %, fibroblast-like cells were presented, and at a confluence of 100 %, a monolayer was formed with cells intimately adjacent to each other. In the culture of oligoastrocytoma, both fibroblast-like cells and islets of closely intertwined fusiform cells were observed. The same was typical for the cells of diffuse protoplasmic astrocytoma. Anaplastic oligodendroglioma during the first week of cultivation was represented mainly by round cells with a contrast agent, which subsequently attached and actively proliferated. At a confluence of 3080 %, fibroblast-like cells were observed, and at 100 %, spindle-shaped cells closely adjacent to each other. In cultures of glioblastomas, no specific character of cell growth was revealed: spindle-shaped, fibroblast-like cells and cells with long processes forming a network were encountered. Glioblastoma cultures against the background of anaplastic astrocytoma were represented by a network of cells with long processes.</p>
<p>At the zero passage, the rate of formation of a 100 % confluence monolayer ranged from 22 to 85 days. At the first passage, the cells reached a full monolayer within 4 to 25 days. At the zero passage, the longest time among all the samples to form the monolayer with a 100 % confluence needed glioblastoma lines on average 59 days. The shortest time to reach a 100 % confluence was required for cells of diffuse astrocytoma, anaplastic oligodendroglioma and glioblastoma against the background of anaplastic astrocytoma 2224 days.</p>
<p><strong>Conclusions.</strong> In our work, it was shown that the explant method ensures the production of viable cells of glial tumors and the possibility of their further cultivation.</p>OncologyneurooncologyCNS tumorsprimary cell lineshuman cell cultivationОнкологиянейроонкологияопухоли ЦНСпервичные клеточные линиикультивирование клеток человека[Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J.B., Belanger K., Brandes A.A., Marosi C., Bogdahn U., Curschmann J., Janzer R.C., Ludwin S.K., Gorlia T., Allgeier A., Lacombe D., Cairncross J.G., Eisenhauer E., Mirimanoff R.O. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987–996.][Cloughesy T.F., Cavenee W.K., Mischel P.S. Glioblastoma. From Molecular Pathology to Targeted Treatment. Annu Rev Pathol Mech Dis 2014; 9: 1–25.][DeAngelis L.M. Global consequences of malignant CNS tumours: a call to action. The Lancet Neurology 2019; 4: 324–325.][Patel A.P., Tirosh I., Trombetta J.J, Shalek A.K., Gillespie S.M., Wakimoto H., Cahill D.P., Nahed B.V., Curry W.T., Martuza R.L., Louis D.N., Rozenblatt-Rosen O., Suvà M.L., Regev A., Bernstein B.E. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 2014; 344:1396–1401.][Polivka J., Holubec L., Kubikova T., Priban V., Hes O., Pivovarcikova K., Treskova I. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme. Anticancer Res 2017; 37: 21–33.][Ledur P.F., Onzi G.R., Zong H., Lenz G. Culture conditions defining glioblastoma cells behavior: what is the impact for novel discoveries? Oncotarget 2017; 40: 69185–69197.][Cree I.A., Glaysher S., Harvey A.L. Efficacy of anti-cancer agents in cell lines versus human primary tumour tissue. Current Opinion in Pharmacology 2010; 4: 375–379.][Mezhevova I.V., Sitkovskaya A.O., Kit O.I. Primary Tumor Cell Cultures: Current Methods of Obtaining and Subcultivation. South Russian Journal of Cancer 2020; 3: 36–49 (in Russian).][Gorelik B., Ziv I., Shohat R., Wick M., Hankins W.D., Sidransky D., Agur Z. Efficacy of Weekly Docetaxel and Bevacizumab in Mesenchymal Chondrosarcoma: A New Theranostic Method Combining Xenografted Biopsies with a Mathematical Model. Cancer Res 2008; 21: 9033–9040.][Freshney R.I. Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications, Sixth Edition. New Jersey: Wiley-Blackwell 2010; 732.][Foo L.C., Allen N.J., Bushong E.A., Ventura P.B., Chung W.S., Zhou L., Cahoy J.D., Daneman R., Zong H., Ellisman M.H., Barres B.A. Development of a Method for the Purification and Culture of Rodent Astrocytes. Neuron 2011; 71: 799–811.][Reiber H. Dynamics of brain-derived proteins in cerebrospinal fluid. Clin Chim Acta 2001; 310: 173–186.][Piaskowski S., Bienkowski M., Stoczynska-Fidelus E., Stawski R., Sieruta M., Szybka M., Papierz W., Wolanczyk M., Jaskolski D.J., Liberski P.P., Rieske P. Glioma cells showing IDH1 mutation cannot be propagated in standard cell culture conditions. Br J Cancer 2011; 104: 968–970.]